Literature DB >> 18954412

Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members.

M Keller1, R Jost, C M Haunstetter, H Sattel, C Schroeter, U Bertsch, F Cremer, P Kienle, M Tariverdian, M Kloor, J Gebert, A Brechtel.   

Abstract

Few studies have reported prospective data on psychosocial outcomes after genetic counselling in families with suspected hereditary non-polyposis colorectal cancer (HNPCC). This prospective study examines the impact of multidisciplinary risk counselling on the psychosocial outcome of 139 affected cancer patients and 233 family members without cancer at risk for HNPCC. Participants completed questionnaires specific to HNPCC before and 8 weeks after attending the familial cancer clinic. Affected patients' levels of distress were closely related to their health status and exceeded that of unaffected individuals, as did worry regarding their relatives' risk. A significant reduction in general anxiety (Hospital Anxiety and Depression Scale), distress specific to familial CRC (Impact of Events Scale) and general cancer worry (Distress Hereditary Disorder) was demonstrated after counselling in both affected patients and unaffected individuals. Reduction in distress was more pronounced in affected patients given a high risk of HNPCC compared with those at intermediate risk. Among unaffected individuals, distress declined regardless of what clinical risk they were assigned. Their perceptions of risk and cancer-related threat declined, while confidence in effective surveillance increased. These results suggest the beneficial effects of multidisciplinary counselling even when high-risk information is conveyed. A patient's previous cancer experience is likely to contribute to clinically relevant distress (15% of those patients), indicating the need for appropriate counselling.

Entities:  

Mesh:

Year:  2008        PMID: 18954412     DOI: 10.1111/j.1399-0004.2008.01089.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  13 in total

1.  Elucidating Genetic Counseling Outcomes from the Perspective of Genetic Counselors.

Authors:  Heather A Zierhut; K M Shannon; D L Cragun; S A Cohen
Journal:  J Genet Couns       Date:  2016-01-19       Impact factor: 2.537

Review 2.  Specific psychosocial issues of individuals undergoing genetic counseling for cancer - a literature review.

Authors:  Willem Eijzenga; Daniela E E Hahn; Neil K Aaronson; Irma Kluijt; Eveline M A Bleiker
Journal:  J Genet Couns       Date:  2013-08-31       Impact factor: 2.537

3.  Billing for medical genetics and genetic counseling services: a national survey.

Authors:  Tabitha A Harrison; Debra Lochner Doyle; Caroline McGowan; Leslie Cohen; Elizabeth Repass; Ruthann B Pfau; Trish Brown
Journal:  J Genet Couns       Date:  2009-10-07       Impact factor: 2.537

4.  Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group.

Authors:  Marina J Corines; Jada G Hamilton; Emily Glogowski; Chris A Anrig; Rachael Goldberg; Kate Niehaus; Erin Salo-Mullen; Megan Harlan; Margaret R Sheehan; Magan Trottier; Asad Ahsraf; Christina Tran; Lauren Jacobs; Rohini Rau-Murthy; Anne G Lincoln; Mark E Robson; Jose G Guillem; Arnold J Markowitz; Kenneth Offit; Zsofia K Stadler
Journal:  J Genet Couns       Date:  2016-10-12       Impact factor: 2.537

Review 5.  Psychosocial Impact of Lynch Syndrome on Affected Individuals and Families.

Authors:  Polymnia Galiatsatos; Heidi Rothenmund; Sylvie Aubin; William D Foulkes
Journal:  Dig Dis Sci       Date:  2015-03-19       Impact factor: 3.199

6.  Validation of a self-concept scale for Lynch syndrome in different nationalities.

Authors:  Helle Vendel Petersen; Katarina Domanska; Pär-Ola Bendahl; Jiahui Wong; Christina Carlsson; Inge Bernstein; Mary Jane Esplen; Mef Nilbert
Journal:  J Genet Couns       Date:  2011-01-26       Impact factor: 2.537

7.  Factors affecting encouragement of relatives among families with Lynch syndrome to seek medical assessment.

Authors:  Noriko Ishii; Masami Arai; Yurie Koyama; Masashi Ueno; Toshiharu Yamaguchi; Keiko Kazuma; Tetsuichiro Muto
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

8.  Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome.

Authors:  Miriam Kuppermann; Grace Wang; Shirley Wong; Amie Blanco; Peggy Conrad; Sanae Nakagawa; Jonathan Terdiman; Uri Ladabaum
Journal:  Cancer       Date:  2012-07-11       Impact factor: 6.860

9.  Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome.

Authors:  Grace Wang; Miriam Kuppermann; Benjamin Kim; Kathryn A Phillips; Uri Ladabaum
Journal:  J Oncol Pract       Date:  2012-05       Impact factor: 3.840

10.  Patient experiences living with pancreatic cancer risk.

Authors:  Meghan Underhill; Donna Berry; Emily Dalton; Jaclyn Schienda; Sapna Syngal
Journal:  Hered Cancer Clin Pract       Date:  2015-05-21       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.